Pharmacokinetics of Cimifugin in Rat Plasma after Oral Administration of the Extract of Saposhnikovia divaricatae Root

Abstract

High performance liquid chromatography (HPLC) coupled with the solid phase extraction method was developed for determining cimifugin (a coumarin derivative; one of Saposhnikovia divaricatae’s constituents) in rat plasma after oral administration of Saposhnikovia divaricatae extract (SDE), and the pharmacokinetics of cimifugin either in SDE or as a single compound was investigated. The HPLC analysis was performed on a commercially available column (4.6 mm × 200 mm, 5 um) with the isocratic emtion of solvent A (Methanol) and solvent B (Water) (A:B=60:40) and the detection wavelength was set at 250 nm. The calibration curve was linear over the range of 0.100-10.040 μg/mL. The limit of detection was 30 ng/mL. At the rat plasma concentrations of 0.402,4.016,10.040 μg/mL, the intra-day precision was 6.21%, 3.98%, and 2.23%; the inter-day precision was 7.59%, 4.26%, and 2.09%, respectively. The absolute recovery was 76.58%, 76.61%, and 77.67%, respectively. When the dosage of SDE was equal to the pure compound calculated by the amount of cimifugin, it was found to have two maximum peaks while the pure compound only showed one peak in the plasma concentration-time curve. The pharmacokinetic characteristics of SDE showed the superiority of the extract and the properties of traditional Chinese medicine.

Key words

Cimifugin, determination in rat plasma, pharmacokinetics - Coumarin derivatives - Saposhnikovia divaricatae root, extract

• References

• 1 Jin GS, Li JD, Pu HS. Studies on the chemical constituents of Ledebouriella seseloides Wolff. Zhongguo Zhong Yao Zha Zhi. 1992; 17: 38-40
• 2 Xiao YQ, Li L, Yang B, Huang LQ. Studies on chemical constituents from the root of Saposhnikovia divaricata (Turcz.) Schischk. Zhongguo Zhong Yao Zha Zhi. 2001; 26: 117-119
• 3 Okuyama E, Hasegawa T, Matsushita T, Fujimoto H, Ishibashi M, Yamazaki M. Analgesic components of Saposhnikovia root (Saposhnikovia diavaricata) . Chem Pharm Bull. 2001; 49: 154-160
• 4 Wang CN, Shiao YJ, Kuo YH, Chen CC, Lin YL. Inducible nitric oxide synthase inhibitors from Saposhnikovin divaricata and Panax quinquefolium . Planta Med. 2000; 66: 644-647
• 5 Kuo YC, Lin YL, Huang CP, Shu JW, Tsai WJ. A tumor cell growth inhibitor from Saposhnikoave divaricata. Cancer Invest. 2002; 20: 955-964
• 6 Tai J, Cheung S. Anti-proliferative and antioxidant activities of Saposhnikovia divaricata. Oncol Rep. 2007; 18: 227-234
• 7 Wang XJ. Progress and future development of the serum pharmacochemistry of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2006; 31: 789-792
• 8 Wang XJ, Zhang N, Sun H, Cao HX, Sun WJ. Study on the collecting method of constituents absorbed into the blood from anti-V capsule. Zhongguo Zhong Yao Za Zhi. 2005; 30: 1654-1657
• 9 China Pharmacopia, Vol. 1. Publication Chemical Industry Press; Beijing: 2005. p. 165
• 10 Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978; 6: 547-558
• 11 Schwartz G. Estimating the dimension of a model. Ann Stat. 1978; 6: 461-464
• 12 Gao HX, Shao SH, Wang GQ. Study progress of Chinese medicine: Fang feng. Jinggangshan Yi Yao Zhuan Bao. 2004; 11: 12-14
• 13 Xue BY, Li W, Li L, Xiao YQ. A pharmacodynamic research on chromone glucosides of Fanfeng. China J Chinese Materia Med. 2004; 25: 297-299